PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis.
Journal of Clinical Investigation.
Times cited: 322
Her-2-neu expression and progression toward androgen independence in human prostate cancer.
Journal of the National Cancer Institute.
Times cited: 319
Heterogeneity of androgen receptor content in advanced prostate cancer.
Times cited: 65